Here's some more proving that people do leave Trials if they have adverse reactions,
Which Giddy falsely stated doesn't happen:
"Approximately 40% of patients with advanced melanoma who received nivolumab combined with ipilimumab in clinical trials discontinued treatment because of adverse events (AEs)"
Easy with Patience, page-117
-
- There are more pages in this discussion • 229 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.1¢ |
Change
-0.001(3.13%) |
Mkt cap ! $27.97M | |||
| Open | High | Low | Value | Volume |
| 3.1¢ | 3.1¢ | 3.0¢ | $21.36K | 696.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 916074 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.3¢ | 120000 | 2 |
View Market Depth
| Last trade - 13.55pm 30/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |